Purchases and Sales Made in Q2 2024 in Krystal Biotech, Inc. (KRYS)
This table provides information about the institutional ownership of Krystal Biotech, Inc. (KRYS) during Q2 2024. The information is specifically focused on institutions that hold shares of Krystal Biotech, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 08, 2024
Q2 2024
|
Times Square Capital Management, LLC
|
SELL
|
- |
-14.1K- 14.53% |
$2.16M - $2.59M
|
83K
$15.8M
|
|
|
Aug 13, 2024
Q2 2024
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-14.3K- 68.59% |
$2.2M - $2.63M
|
6.57K
$1.25M
|
|
|
Aug 14, 2024
Q2 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-15.9K- 16.97% |
$2.44M - $2.92M
|
77.8K
$14.8M
|
|
|
Aug 07, 2024
Q2 2024
|
First Turn Management, LLC
Del Mar, CA |
SELL
|
- |
-21.6K- 16.53% |
$3.31M - $3.97M
|
109K
$20.8M
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-22.5K- 44.04% |
$3.44M - $4.13M
|
28.6K
$5.44M
|
|
|
Aug 13, 2024
Q2 2024
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
SELL
|
- |
-26.2K- 12.05% |
$4.02M - $4.82M
|
192K
$36.5M
|
|
|
Aug 14, 2024
Q2 2024
|
Man Group PLC
London, X0 |
SELL
|
- |
-26.6K- 27.76% |
$4.07M - $4.89M
|
69.3K
$13.2M
|
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-30.9K- 59.3% |
$4.73M - $5.68M
|
21.2K
$4.04M
|
|
|
Aug 14, 2024
Q2 2024
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-43.8K- 70.89% |
$6.71M - $8.05M
|
18K
$3.43M
|
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-54.1K- 95.46% |
$8.28M - $9.93M
|
2.57K
$489K
|
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-58.5K- 8.88% |
$8.95M - $10.7M
|
600K
$114M
|
|
|
Aug 14, 2024
Q2 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-64.4K- 51.84% |
$9.86M - $11.8M
|
59.8K
$11.4M
|
|
|
Aug 14, 2024
Q2 2024
|
Braidwell LP
Stamford, CT |
SELL
|
- |
-69.9K- 39.48% |
$10.7M - $12.8M
|
107K
$20.4M
|
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-71K- 86.53% |
$10.9M - $13M
|
11K
$2.1M
|
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-96.1K- 94.6% |
$14.7M - $17.6M
|
5.48K
$1.04M
|
|
|
Oct 07, 2024
Q2 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-100K- 20.31% |
$15.3M - $18.4M
|
392K
$74.7M
|
|
|
Aug 14, 2024
Q2 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-100K- 20.31% |
$15.3M - $18.4M
|
392K
$74.7M
|
|
|
Aug 14, 2024
Q2 2024
|
Avoro Capital Advisors LLC
New York, NY |
SELL
|
- |
-123K- 4.8% |
$18.8M - $22.5M
|
2.43M
$463M
|
|
|
Aug 05, 2024
Q2 2024
|
Jennison Associates LLC
|
SELL
|
- |
-150K- 22.41% |
$23M - $27.6M
|
520K
$99.1M
|
|
|
Aug 14, 2024
Q2 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-487K- 32.3% |
$74.6M - $89.5M
|
1.02M
$194M
|